Dx Firms Comply with FDA Instructions on Swine Flu Test Marketing | GenomeWeb

NEW YORK (GenomeWeb News) – All three firms cited by the US Food and Drug Administration last week for allegedly marketing tests for the 2009 H1N1 Flu Virus, also known as the swine flu, that had not been cleared for marketing by the agency have complied with FDA's instructions, they have confirmed for GenomeWeb Daily News.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.